Is Anteris Technologies Global Corp. Common Stock (AVR) overvalued? · rev $429.0K
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on US.
This page asks whether Anteris Technologies Global Corp. Common Stock (AVR) looks expensive on cached numbers — not a short thesis.
Latest reported AVR revenue for 2025-09-30 was $429.0K. Net income was -$22.2M. Revenue was down 30.6% from 2025-06-30 to 2025-09-30. AVR currently screens at market cap $287.2M.
AVR currently screens at market cap $287.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AVR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AVR stock page for the full model, not this heading.
Not investment advice.